D. E. Shaw & Co., Inc. Pulse Biosciences, Inc. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.48 - $4.28 $102,399 - $296,128	-69,189 Reduced 68.49%	31,827 $49,000
Q1 2022 May 16, 2022	BUY	$4.21 - $14.79 $425,277 - $1.49 Million	101,016 New	101,016 $491,000
Q3 2021 Nov 15, 2021	SELL	$17.25 - $26.63 $302,358 - $466,770	-17,528 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.31 - $23.64 $285,881 - $414,361	17,528 New	17,528 $287,000
Q1 2021 May 17, 2021	SELL	$22.43 - $44.27 $277,930 - $548,549	-12,391 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.66 - $24.5 $144,479 - $303,579	12,391 New	12,391 $296,000

4.8M

138K

96.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $541M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.